Published by Benjamin Chiou on 11th October 2024
(Sharecast News) - JPMorgan Cazenove has cut its recommendation for Vistry from 'overweight' to 'neutral' and slashed its target price more than a third after a profit warning from the housebuilder on Tuesday, saying that the company needs to "restore confidence" among investors.